Measure
Number
Theme
Measure
Description & Provenance
Name of KPI
Numerator
Denominator
Period Type
Frequency
Data Source
Numerator
Data Source
Denominator
Data
presentation
Target
Interpretation
Guidance
Construction
Data Quality
Concerns
Notes_1
HPB01
Domain 3: Helping
Proportion of patients with adenocarcinoma of
people to recover from the pancreas who have a curative resection
episodes of ill health or
following injury
Number of patients who have curative Number of patients with adenocarcinoma of the Annual
resection
pancreas
Annual
Provider
Provider
HPB02
Domain 3: Helping
Mortality rate within 30 days of cureative
people to recover from resection for adenocarcinoma of the pancreas
episodes of ill health or
following injury
Number of patients who die within 30 Number of patients with adenocarcinoma of the Annual
days of curative resection
pancreas who have a curative resection
Annual
Provider
Provider
HPB03
Domain 3: Helping
Mortality rate within 90 days of curative
people to recover from resection for adenocarcinoma of the pancreas
episodes of ill health or
following injury
Number of patients who die within 90 Number of patients with adenocarcinoma of the Annual
days of curative resection
pancreas who have a curative resection
Annual
Provider
Provider
HPB04
Domain 3: Helping
5 year survival of patients with adenocarcinoma
people to recover from of the pancreas - all patients discussed at MDT
episodes of ill health or
following injury
Annual
Annual
TBC
TBC
further guidance
needed - not to be
collected currently
HPB05
Domain 3: Helping
5 year survival of patients with adenocarcinoma
people to recover from of the pancreas - all patients discussed at MDT
episodes of ill health or who undergo resection with curative intent
following injury
Annual
Annual
TBC
TBC
further guidance
needed - not to be
collected currently
HPB07
Domain 3: Helping
LOS after pancreatico-duodenectomy (J56X) for
people to recover from pancreatic adenocarcinoma
episodes of ill health or
following injury
Number of days (LOS)
Number of pancreatico-duodenectomy (J56X)
for pancreatic adenocarcinoma in reporting
period
Annual
Annual
HES
HES
HPB08
Domain 3: Helping
Emergency readmission within 30 days of
people to recover from pancreatico-duodenectomy for pancreatic
episodes of ill health or adenocarcinoma
following injury
From denominator, number of
emergency readmissions within 30
days
Number of pancreatico-duodenectomy (J56X)
for pancreatic adenocarcinoma in reporting
period
Annual
Annual
Provider
Provider
HPB09
Domain 3: Helping
Re-operation rates within 30 days of pancreaticopeople to recover from duodenectomy for pancreatic adenocarcinoma
episodes of ill health or
following injury
From denominator, number of re
operations within 30 days
Number of pancreatico-duodenectomy (J56X)
for pancreatic adenocarcinoma in reporting
period
Annual
Annual
Provider
Provider
HPB10
Domain 3: Helping
Proportion of patients with pancreatic
people to recover from adenocarcinoma who do not undergo curative
episodes of ill health or resection who receive palliative chemotherapy
following injury
From denominator, number receiving Number of patients with pancreatic
palliative chemotherapy
adenocarcinoma not undergoing curative
resection
Annual
Annual
Provider
Provider
HPB13
Domain 3: Helping
Mean duration from date of referral by GP (or
people to recover from emergency admission to hospital) to curative
episodes of ill health or resection
following injury
Total length of time from referral or
emergency admissions
Annual
Annual
Provider
Provider
HPB14
Domain 3: Helping
people to recover from
episodes of ill health or
following injury
From denominator, number receiving Number of patients with pancreatic head or
curative resection without initial stent uncinate adenocarcinoma with serum bilirubin
placement
<200mg/dl at presentation
Annual
Annual
Provider
Provider
HPB16
Domain 3: Helping
Proportion of patients with colorectal liver
people to recover from metastases whose imaging is discussed at HPB
episodes of ill health or MDT
following injury
From denominator, number whose
imaging is discussed at HPB MDT
Number of patients with colorectal liver
metastases
Annual
Annual
Provider
Provider
HPB17
Domain 3: Helping
Proportion of patients with colorectal liver
people to recover from metastases undergoing resection
episodes of ill health or
following injury
From denominator, number
undergoing resection
Number of patients with colerectal liver
metastases
Annual
Annual
Provider
Provider
HPB18
Domain 3: Helping
Length of stay after right hemi-hepatectomy for
people to recover from colorectal cancer liver metastases
episodes of ill health or
following injury
Length of stay (in days)
Number of patients having right hemihepatectomy for colorectal cancer liver
metastases
Annual
Annual
Provider
Provider
HPB19
Domain 4: Ensuring
that people have a
positive experience of
care
Domain 5: Treating
and caring for people
in a safe environment
and protecting them
from avoidable harm
Emergency readmission rate at 30 days after right
hemi-hepatectomy for colorectal cancer liver
metastases
From denominator, number of
emergency readmissions within 30
days
Number of patients having right hemihepatectomy for colorectal cancer liver
metastases
Annual
Annual
Provider
Provider
30 day mortality after right hemi-hepatectomy
for colorectal cancer liver metastases
Number of patients who die within 30 Number of patients having right hemidays of right hemi-hepatectomy
hepatectomy for colorectal cancer liver
metastases
Annual
Annual
Provider
Provider
HPB20
Proportion of patients with pancreatic head or
uncinate adenocarcinoma with serum bilirubin
<200mg/dl at presentation receiving curative
resection without initial stent placement
Number of patients having curative resection
HPB21
HPB22
HPB23
HPB24
Domain 4: Ensuring
that people have a
positive experience of
care
Domain 4: Ensuring
that people have a
positive experience of
care
Domain 4: Ensuring
that people have a
positive experience of
care
Domain 5: Treating
and caring for people
in a safe environment
and protecting them
from avoidable harm
90 day mortality after right hemi-hepatectomy
for colorectal cancer liver metastases
Number of patients who die within 90 Number of patients having right hemidays of right hemi-hepatectomy
hepatectomy for colorectal cancer liver
metastases
Annual
Annual
Annual
Annual
Annual
Annual
30 day survival for patients with colorectal liver
metastases receiving ablation without resection,
with curative intent
Annual
Annual
Domain 4: Ensuring
that people have a
positive experience of
care
Domain 4: Ensuring
that people have a
positive experience of
care
Domain 5: Treating
and caring for people
in a safe environment
and protecting them
from avoidable harm
5 year survival for patients with colorectal liver
metastases receiving ablation without resection,
with curative intent
Annual
Annual
Domain 4: Ensuring
that people have a
positive experience of
care
Domain 5: Treating
and caring for people
in a safe environment
and protecting them
from avoidable harm
Provider
5 year survical after right hemi-hepatectomy for
colorectal cancer liver metastases
Proportion of patients with colorectal liver
metastases receiving ablation without resection,
with curative intent
From denominator, number receiving Number of patients with colorectal liver
ablation without resection with
metastases
curative intent
further guidance
needed - not to be
collected currently
TBC
TBC
Provider
Provider
further guidance
needed - not to be
collected currently
TBC
HPB25
HPB27
HPB28
HPB29
HPB30
Percentage of patients with hepatocellular
carcinoma receiving treatment with curative
intent
from denominator, number receiving
treatment with curative intent
Number of patients with hepatocellular
carcinoma
Annual
Annual
Percentage of patients with hepatocellular
carcinoma receiving liver transplant
from denominator, number receiving
liver transplant
Number of patients with hepatocellular
carcinoma
Annual
Annual
Median survival for patients with HCC treated
with curative intent
Annual
Annual
Median survival for patients with HCC treated
with palliative intent
Annual
Annual
Annual
Annual
Annual
Annual
TBC
TBC
Provider
Provider
Provider
Provider
further guidance
needed - not to be
collected currently
TBC
HPB32
Domain 4: Ensuring
Median survival after liver transplant for benign
that people have a
disease
positive experience of
care
Domain 5: Treating
5 year survival after liver transplant for HCC
and caring for people
in a safe environment
and protecting them
from avoidable harm
TBC
further guidance
needed - not to be
collected currently
TBC
further guidance
needed - not to be
collected currently
TBC
HPB31
Provider
TBC
further guidance
needed - not to be
collected currently
TBC
TBC
further guidance
needed - not to be
collected currently
TBC
TBC
ROCR/OR/2230/001MAND